TRIB
Trinity Biotech Plc
NASDAQ · Healthcare · Medical - Diagnostics & Research · IE
$7.23
−0.48%Next report
Analyst consensus
- Next report date
- Dec 10, 2026
- EPS estimate
- -$8.40
- Revenue estimate
- $10.0M
Latest reported
- Last report date
- Jun 16, 2026
- EPS actual
- -$0.23
- EPS estimate
- -$0.31
- Revenue actual
- —
- Revenue estimate
- $10.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -22.0%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jun 16, 2026 | -$0.31 | -$0.23 | Beat 25.81% | — |
| Dec 23, 2025 | -$0.51 | -$0.32 | Beat 37.25% | $14.2M |
| May 15, 2025 | -$0.30 | -$1.02 | Miss -240.00% | $15.9M |
| Jan 29, 2025 | -$0.54 | -$0.06 | Beat 88.92% | $15.9M |
| Nov 15, 2024 | -$0.54 | -$0.43 | Beat 20.37% | $15.2M |
| May 23, 2024 | -$3.00 | -$0.37 | Beat 87.67% | $13.4M |
| Oct 3, 2023 | -$0.09 | -$1.00 | Miss -1011.11% | $14.7M |
| Sep 6, 2023 | — | -$0.06 | — | $19.5M |
| Mar 23, 2023 | -$0.06 | -$0.90 | Miss -1400.00% | $14.8M |
| Dec 15, 2022 | -$0.20 | -$0.90 | Miss -350.00% | $18.0M |
| Jun 30, 2022 | -$0.20 | -$0.40 | Miss -100.00% | $18.5M |
| Dec 31, 2021 | — | $0.02 | — | $19.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 10, 2026